Back To: Form List

PARTICIPATION IN MEDICINAL CANNABIS RESEARCH INFORMED CONSENT

Purpose

Southern Cross Cannabis Clinic is undertaking a research project to assess the effectiveness of medicinal cannabis in reducing the drug burden and improving quality of life outcomes for chronic pain anxiety and PTSD management within community-based medicine.

Participation

Participation in this study is available to patients who have been assessed for eligibility under the TGA guidelines to access medicinal cannabis to treat their condition. These patients will be required to continue medicinal cannabis six months and complete other aspects of the research project including blood tests pain and mental health questionnaires.

Research Approval

This research has been approved by the University of Wollongong’s Human Research Ethics Committee(HREC)and is being closely monitored by the Centre for Health Research Illawarra and Shoalhaven Population (CHRISP).

Participant Information

Your appointments and treatment will be undertaken by our experienced doctors on site at Southern Cross Cannabis Clinic. As this study is unfunded, it will not be possible to reimburse you the cost of any expenses related to this research project and you will be responsible for paying for your appointments as well as the purchase of any medications, including medicinal cannabis, associated with your treatment.
Any risks associated with your treatment, possible side effects and other important information with be discussed with you by your treating doctor during your initial consultation. Our website, www.southerncrosscannabisclinic.com.au also contains important information for patients that you may choose to access. If you have any other questions, please direct these to your treating doctor, or research project lead.

Withdraw from Research

You have a right to withdraw from this research at any time.
You will also be excluded from this study if you do not meet the criteria for use of medicinal cannabis under the TGA guidelines, if you do not continue treatment for at least six months, if you do not complete the required blood tests or participate in the other research questionnaires.
Patients that do not have capacity to consent will not be included in this trial.

Project Lead Contact Details

Dr Michael Mumford (MBBS, FRACGP) (02) 4288 0511.

Privacy

Your medical records, including those associated with this research, are private and confidential. They are securely stored in our practice management software and are subject to the requirements of the National Privacy Principles. For more information, please visit www.oaic.gov.au/privacy/privacy-act/the-privacy-act.
Health professionals directly involved in your care for this study can access your information, but only as necessary for their work. Just as they cannot disclose anything about your healthcare to another person unless it is directly relevant to your healthcare or this research, our health professionals cannot disclose anything to you about otherpatients.
It is a legal requirement that all personal information associated with this research will be securely stored for 15 years before it can be destroyed.

*I agree that I have been provided details about this research project and I have been given an opportunity to ask any questions that I may have. I also agree that by signing this document, I am providing my informed consent to participate in this research project.